123 related articles for article (PubMed ID: 11771665)
1. Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women.
Heshmati HM; Khosla S; Robins SP; O'Fallon WM; Melton LJ; Riggs BL
J Bone Miner Res; 2002 Jan; 17(1):172-8. PubMed ID: 11771665
[TBL] [Abstract][Full Text] [Related]
2. Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women.
McKane WR; Khosla S; Risteli J; Robins SP; Muhs JM; Riggs BL
Proc Assoc Am Physicians; 1997 Mar; 109(2):174-80. PubMed ID: 9069586
[TBL] [Abstract][Full Text] [Related]
3. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
4. [Relation of serum growth hormone and estradiol levels and osteoporosis in postmenopausal women].
Li G; Zeng M
Zhonghua Yi Xue Za Zhi; 1990 Jan; 70(1):16-9, 2. PubMed ID: 2157532
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
[TBL] [Abstract][Full Text] [Related]
6. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
[TBL] [Abstract][Full Text] [Related]
7. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
[TBL] [Abstract][Full Text] [Related]
8. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
[TBL] [Abstract][Full Text] [Related]
9. Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men.
Doran PM; Riggs BL; Atkinson EJ; Khosla S
J Bone Miner Res; 2001 Nov; 16(11):2118-25. PubMed ID: 11697809
[TBL] [Abstract][Full Text] [Related]
10. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
11. Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels.
Uebelhart B; Herrmann F; Pavo I; Draper MW; Rizzoli R
J Bone Miner Res; 2004 Sep; 19(9):1518-24. PubMed ID: 15312253
[TBL] [Abstract][Full Text] [Related]
12. Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women.
Cosman F; Nieves J; Woelfert L; Shen V; Lindsay R
J Bone Miner Res; 1998 Jun; 13(6):1051-5. PubMed ID: 9626638
[TBL] [Abstract][Full Text] [Related]
13. Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women.
Charatcharoenwitthaya N; Khosla S; Atkinson EJ; McCready LK; Riggs BL
J Bone Miner Res; 2007 May; 22(5):724-9. PubMed ID: 17295604
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous EDTA treatment on serum parathyroid hormone (1-84) and biochemical markers of bone turnover.
Guldager B; Brixen KT; Jørgensen SJ; Nielsen HK; Mosekilde L; Jelnes R
Dan Med Bull; 1993 Nov; 40(5):627-30. PubMed ID: 8299406
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
Jensen J; Christiansen C; Rødbro P
N Engl J Med; 1985 Oct; 313(16):973-5. PubMed ID: 4047104
[TBL] [Abstract][Full Text] [Related]
16. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial.
Zhang G; Qin L; Shi Y
J Bone Miner Res; 2007 Jul; 22(7):1072-9. PubMed ID: 17419678
[TBL] [Abstract][Full Text] [Related]
17. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
18. A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer.
McCaig FM; Renshaw L; Williams L; Young O; Murray J; Macaskill EJ; McHugh M; Hannon R; Dixon JM
Breast Cancer Res Treat; 2010 Feb; 119(3):643-51. PubMed ID: 19941160
[TBL] [Abstract][Full Text] [Related]
19. [Relation of estrogen and bone loss in postmenopausal women].
Li XY
Zhonghua Fu Chan Ke Za Zhi; 1989 Sep; 24(5):279-81, 317. PubMed ID: 2620581
[TBL] [Abstract][Full Text] [Related]
20. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C
J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
